Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 91201-91250 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05192122
Free from Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MRD
PHASE1Recruiting
50 participants
Started: Dec 31, 2021 · Completed: Jan 31, 2029
1 condition1 sponsor1 location
NCT05139641
Multidisciplinary Shared Decision Making of Fertility Preservation in Young Women With Breast Cancer
NANot yet recruiting
4,100 participants
Started: Dec 31, 2021 · Completed: Dec 31, 2028
1 condition2 sponsors1 location
NCT05488379
Child Healthcare at MATER - Pediatric Study
NARecruiting
108 participants
Started: Dec 31, 2021 · Completed: Oct 31, 2025
1 condition3 sponsors1 location
NCT05169021
Folic Acid and Intensive Antihypertensive Therapy for Hypertension With CSVD
PHASE4Not yet recruiting
15,000 participants
Started: Dec 31, 2021 · Completed: Dec 31, 2028
2 conditions1 sponsor1 location
NCT05176964
Chemotherapy and Tislelizumab With Split-course HFRT for Locally Advanced Rectal Cancer
N/ARecruiting
50 participants
Started: Dec 31, 2021 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT04890821
Early Feasibility Study of the Cardiac Implants Percutaneous Ring Annuloplasty System
NARecruiting
15 participants
Started: Dec 31, 2021 · Completed: Sep 30, 2027
1 condition1 sponsor2 locations
NCT05126914
Multicentre Real-life Follow-up Study of Rare Epileptic Syndromes in Children and Adolescents
N/ANot yet recruiting
1,000 participants
Started: Dec 31, 2021 · Completed: Dec 31, 2028
3 conditions2 sponsors1 location
NCT05638425
Radiotherapy Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of NSCLC Patients With Symptomatic Brain Metastases
N/ARecruiting
20 participants
Started: Dec 31, 2021 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT05189093
Recombinant Humanized Anti-CD47/PD-1 Bifunctional Antibody HX009 in Patients With Relapsed/Refractory Lymphoma
PHASE1/PHASE2Recruiting
99 participants
Started: Dec 31, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05266534
The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Without Using Haemostatic Tourniquets
NARecruiting
162 participants
Started: Dec 30, 2021 · Completed: Dec 30, 2026
1 condition1 sponsor1 location
NCT05510505
GVHD Prophylaxis by Addition of CD20 Monoclonal Antibody to the Conditioning Regimen in SAA With Treatment of Allo-HSCT
PHASE2Recruiting
100 participants
Started: Dec 30, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04905082
HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics
NAActive, not recruiting
465 participants
Started: Dec 30, 2021 · Completed: Dec 31, 2025
7 conditions2 sponsors1 location
NCT04181138
Primary Sclerosing Cholangitis in Children
N/ARecruiting
1,000 participants
Started: Dec 30, 2021 · Completed: May 31, 2029
3 conditions2 sponsors12 locations
NCT05326204
1 Versus 2 Hours Post Meal Glucose Monitoring in Gestational Diabetes on Treatment
N/ARecruiting
2,954 participants
Started: Dec 30, 2021 · Completed: Dec 29, 2025
2 conditions1 sponsor1 location
NCT04894734
Spinal Cord Stimulation (SCS) for Spinal Cord Injury (SCI)
NARecruiting
30 participants
Started: Dec 30, 2021 · Completed: Oct 31, 2027
6 conditions1 sponsor1 location
NCT05201287
VIA Disc NP Pilot for Patients With Symptomatic Degenerated Discs
NAActive, not recruiting
35 participants
Started: Dec 30, 2021 · Completed: Dec 27, 2024
3 conditions2 sponsors6 locations
NCT06456697
Pipeline Embolization Device for the Treatment of Intracranial Aneurysms on the Long Term Safety and Efficacy
N/ARecruiting
482 participants
Started: Dec 30, 2021 · Completed: Dec 30, 2024
1 condition10 sponsors1 location
NCT04799548
A Phase II Study of TACE Plus PD-1 Antibody in the Locally Advanced Stomach Adenocarcinoma
PHASE2Recruiting
71 participants
Started: Dec 30, 2021 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT04514744
Dynamic Proteomics and Integrated Rates of Muscle Protein Synthesis During an Acute Period of Loading and Unloading
NAActive, not recruiting
16 participants
Started: Dec 30, 2021 · Completed: Jul 1, 2025
4 conditions1 sponsor1 location
NCT05225948
Effects of Remote Ischemic Conditioning on Dynamic Cerebral Autoregulation, Blood Pressure and Heart Rate Variability in Patients With Cerebral Small Vessel Disease
NARecruiting
100 participants
Started: Dec 30, 2021 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05197530
Imaging of Lymphatic Vessels in People with Rheumatoid Arthritis (RA)
PHASE1Recruiting
40 participants
Started: Dec 30, 2021 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT06950307
Hypofractionation for Prostate Cancer in Africa: A Feasibility Study
N/AActive, not recruiting
182 participants
Started: Dec 30, 2021 · Completed: Mar 1, 2029
1 condition5 sponsors3 locations
NCT06779747
Evaluation of Different Diagnostic Therapeutic Strategies in Patients with Thyroid Pathology
N/ARecruiting
5,850 participants
Started: Dec 30, 2021 · Completed: Dec 30, 2041
4 conditions1 sponsor1 location
NCT05143957
A Study to Evaluate Sapablursen (Formerly ISIS 702843, IONIS-TMPRSS6-LRx) in Patients With Polycythemia Vera
PHASE2Active, not recruiting
50 participants
Started: Dec 30, 2021 · Completed: Jun 30, 2026
1 condition1 sponsor18 locations
NCT05203679
Evaluation of the Safety and Efficacy of Hemophilia B Gene Therapy Drug
PHASE2/PHASE3Active, not recruiting
32 participants
Started: Dec 30, 2021 · Completed: Jun 30, 2028
1 condition1 sponsor9 locations
NCT05224635
The PROspective Observational Vascular Injury Trial (PROOVIT)
N/AEnrolling by invitation
5,718 participants
Started: Dec 30, 2021 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT05935267
Thoracostomy Tube Irrigation: a Multi-Center Trial
N/AActive, not recruiting
1,000 participants
Started: Dec 30, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05053646
This is a Study to Verify if Marrow Venting Procedure Can Improve Meniscal Suture Healing
NARecruiting
80 participants
Started: Dec 29, 2021 · Completed: Oct 1, 2030
1 condition1 sponsor2 locations
NCT06126965
Phase III Study of KX-826 With Adult Male Patients With AGA
PHASE3Active, not recruiting
740 participants
Started: Dec 29, 2021 · Completed: May 31, 2024
1 condition2 sponsors26 locations
NCT06252948
Gut Microbiome Studies in Patients With POEMS Syndrome and Other Plasma Cell Disorders
N/ARecruiting
240 participants
Started: Dec 29, 2021 · Completed: Dec 29, 2028
1 condition1 sponsor1 location
NCT05170503
Neoadjuvant Immunochemotherapy in Locally Advanced Esophagogastric Junction Adenocarcinoma
PHASE2Recruiting
37 participants
Started: Dec 29, 2021 · Completed: Jan 1, 2029
1 condition1 sponsor1 location
NCT04947319
Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study)
PHASE2Recruiting
112 participants
Started: Dec 29, 2021 · Completed: Mar 31, 2027
2 conditions1 sponsor45 locations
NCT04945460
A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)
PHASE2Active, not recruiting
164 participants
Started: Dec 29, 2021 · Completed: Jan 30, 2026
1 condition1 sponsor119 locations
NCT05630963
Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression
N/ARecruiting
228 participants
Started: Dec 29, 2021 · Completed: Feb 28, 2027
1 condition2 sponsors1 location
NCT05120505
Metformin in Children With Fragile X Syndrome
PHASE4Recruiting
20 participants
Started: Dec 29, 2021 · Completed: Dec 30, 2025
2 conditions1 sponsor1 location
NCT05077332
LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)
PHASE2Active, not recruiting
2,000 participants
Started: Dec 29, 2021 · Completed: Dec 31, 2025
12 conditions2 sponsors1 location
NCT05199272
A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies
PHASE1/PHASE2Active, not recruiting
141 participants
Started: Dec 29, 2021 · Completed: Mar 31, 2025
9 conditions1 sponsor13 locations
NCT05020275
Resistance to the Tyrosine Kinase Inhibitor Osimertinib and Pharmacokinetics in Non-small Cell Lung Cancer
N/AActive, not recruiting
60 participants
Started: Dec 29, 2021 · Completed: Mar 16, 2027
1 condition1 sponsor4 locations
NCT04396418
Stroke Prevention and Rhythm Control Therapy STEEER-AF
NAActive, not recruiting
1,732 participants
Started: Dec 29, 2021 · Completed: Dec 30, 2025
1 condition2 sponsors70 locations
NCT05902247
Actium-225-Prostate Specific Membrane Antigen Imaging & Therapy
PHASE1Recruiting
30 participants
Started: Dec 29, 2021 · Completed: Dec 29, 2025
1 condition2 sponsors1 location
NCT05055791
A Study to Evaluate the Safety and Tolerance of SYHX1903 in Patients With Relapsed/Refractory Hematologic Malignancies
PHASE1/PHASE2Not yet recruiting
312 participants
Started: Dec 29, 2021 · Completed: Sep 20, 2026
3 conditions1 sponsor0 locations
NCT05045066
Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients
EARLY_PHASE1Recruiting
200 participants
Started: Dec 29, 2021 · Completed: Aug 31, 2029
4 conditions1 sponsor2 locations
NCT05144997
Lorlatinib Continuation Study
PHASE4Active, not recruiting
74 participants
Started: Dec 28, 2021 · Completed: Dec 28, 2026
2 conditions1 sponsor35 locations
NCT05026905
A Phase II Randomized Study of Gemcitabine and Nab-paclitaxel in Combination With S- 1/LV (GASL) or Oxaliplatin (GAP) as First-line Treatment for Metastatic Pancreatic Cancer
PHASE2Active, not recruiting
66 participants
Started: Dec 28, 2021 · Completed: Dec 31, 2027
1 condition5 sponsors4 locations
NCT05152732
Safety and Tolerability of VGB-R04 in Patients With Haemophilia B
EARLY_PHASE1Recruiting
3 participants
Started: Dec 28, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05171569
Post Discharge After Surgery Virtual Care With Remote Automated Monitoring Technology-3 Trial
NAActive, not recruiting
2,500 participants
Started: Dec 28, 2021 · Completed: May 31, 2025
1 condition2 sponsors2 locations
NCT05017545
Carfilzomib and Belatacept for Desensitization
PHASE1/PHASE2Recruiting
15 participants
Started: Dec 28, 2021 · Completed: Feb 28, 2028
1 condition5 sponsors1 location
NCT05126589
Respiratory Virus Metagenomics After COVID-19
N/ARecruiting
500 participants
Started: Dec 28, 2021 · Completed: Jan 31, 2027
1 condition1 sponsor1 location
NCT05139602
A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy
PHASE2Active, not recruiting
210 participants
Started: Dec 28, 2021 · Completed: Jan 31, 2026
1 condition1 sponsor54 locations
NCT05167071
HBM4003 Combine With Toripalimab in Patients With Advanced NEN and Other Solid Tumors Study
PHASE1Active, not recruiting
53 participants
Started: Dec 28, 2021 · Completed: Jun 30, 2026
3 conditions1 sponsor1 location